Pandemic Perspectives: What’s The New Normal For The Business Of Biopharma?
A Biotech Roundtable, Part 2
In Part 2 of Scrip’s roundtable, execs from Athira, Cartesian, Cyclacel, Tonix and VOZ Advisors discuss how the pandemic brought in new investors and triggered strategic shifts for the biopharma industry.
